tbResList Print — Lae Laetrile B17 Amygdalin

Filters: qv=112, qv2=%, rfv=%

Product

Lae Laetrile B17 Amygdalin
Features: Sourced from apricot kernels
Description: <b>Banned</b> in some states. May cause cyanide poisoning.<br>
Laetrile B17 (Amygdalin )<br>
Summary:<br>
-Activation of the caspase-3 protease and downregulating Bcl-2, upregulates BAX<br>
-Bax-to-Bcl-2 ratio and caspase-3 activity were increased<br>
-Inhibits NF-kβ and NLRP3 signaling pathways<br>
-Release of cyanide through the decomposition of amygdalin by the gut microfloral B-glucosidase enzyme. (bad)<br>
-IV might be better to avoid the digestive tract which could convert to hydrogen cyanide.????<br>
<br>
Selective Toxicity (some challenges to this statement)<br>
The amygdalin itself is not toxic, but the HCN released from it causes the amygdalin toxic effect [35]. Cancer cells are dominant in anaerobic glycolysis and β -glucosidase is at its highest activity in lactate-induced acidic conditions [36]. Therefore, cancer cells have a high level of the unlocking enzyme β -glucosidase activity that breaks down amygdalin, leading to the release of HCN
On the other hand, normal cells are normo-oxygenated and contain low levels of the β -glucosidase enzyme as well as high levels of rhodanese enzyme which transforms hydrogen cyanide into harmless thiocyanate [46, 47]. Thiocyanate has positive effects on organisms such as lowering blood pressure and is also considered a precursor for vitamin B12.<br>
<br>
It is poisonous when combined with plant-rich beta-glucosidase.<br>
Upon ingestion, amygdalin is hydrolyzed to cyanide by beta-glucuronidase in the small intestine [2]. Oral intake of 500 mg of amygdalin may contain as much as 30 mg of cyanide [3]. Oral amygdalin is estimated to be 40 times more potent than intravenous form due to its enzymatic conversion to hydrogen cyanide in the gastrointestinal tract [4]. <br>

Pathway results for Effect on Cancer / Diseased Cells

Cell Death

Akt↓, 1,   BAX↑, 2,   Bcl-2↓, 2,   Casp3↑, 2,   TumCD↑, 1,  

Transcription & Epigenetics

other↑, 4,   other↓, 1,   other∅, 1,   other↝, 1,  

Cell Cycle & Senescence

CDK1↓, 1,   CycB/CCNB1↓, 1,   p19↑, 1,   TumCCA↑, 1,  

Proliferation, Differentiation & Cell State

mTOR↓, 1,   TumCG↓, 1,  

Migration

E-cadherin↝, 1,   E-cadherin↑, 1,   N-cadherin↝, 1,   TumCP↓, 1,  

Immune & Inflammatory Signaling

COX2↝, 1,  

Drug Metabolism & Resistance

eff↑, 1,  
Total Targets: 21

Pathway results for Effect on Normal Cells

Functional Outcomes

toxicity↝, 1,  
Total Targets: 1

Research papers

Year Title Authors PMID Link Flag
2023Amygdalin as a Promising Anticancer Agent: Molecular Mechanisms and Future Perspectives for the Development of New Nanoformulations for Its DeliveryMaria SpanoudakiPMC10531689https://pmc.ncbi.nlm.nih.gov/articles/PMC10531689/0
2022Amygdalin: A Review on Its Characteristics, Antioxidant Potential, Gastrointestinal Microbiota Intervention, Anticancer Therapeutic and Mechanisms, Toxicity, and EncapsulationHassan BarakatPMC9599719https://pmc.ncbi.nlm.nih.gov/articles/PMC9599719/0
2022The Postulated Mechanism of Action of Amygdalin (Vitamin B17) on Cancer CellsMohamed Ali El desoukyhttps://www.researchgate.net/publication/365732391_The_Postulated_Mechanism_of_Action_of_Amygdalin_Vitamin_B17_on_Cancer_Cells0
2021Synthesis of polygonal chitosan microcapsules for the delivery of amygdalin loaded silver nanoparticles in breast cancer therapyAnushree Pandeyhttps://www.researchgate.net/publication/348878042_Synthesis_of_polygonal_chitosan_microcapsules_for_the_delivery_of_amygdalin_loaded_silver_nanoparticles_in_breast_cancer_therapy0
2019Can Amygdalin Provide any Benefit in Integrative Anticancer Treatment?Alžběta Třísková31610669https://pubmed.ncbi.nlm.nih.gov/31610669/0
2019Recent updates and future perspectives about amygdalin as a potential anticancer agent: A reviewJiamin ShiPMC6558459https://pmc.ncbi.nlm.nih.gov/articles/PMC6558459/0
2018Molecular mechanism of amygdalin action in vitro: review of the latest researchPrzemysław Liczbiński29486614https://pubmed.ncbi.nlm.nih.gov/29486614/0
2018Amygdalin from Apricot Kernels Induces Apoptosis and Causes Cell Cycle Arrest in Cancer Cells: An Updated ReviewMohammad Saleem29308747https://pubmed.ncbi.nlm.nih.gov/29308747/0
2018Effects of the Gut microbiota on Amygdalin and its use as an anti-cancer therapy: Substantial review on the key components involved in altering dose efficacy and toxicityVani JaswalPMC5986699https://pmc.ncbi.nlm.nih.gov/articles/PMC5986699/0
2017Physician Beware: Severe Cyanide Toxicity from Amygdalin Tablets IngestionTam DangPMC5587935https://pmc.ncbi.nlm.nih.gov/articles/PMC5587935/0
2016Vitamin B17 and its Proposed Application in Treating CancerNitin Srivastavhttps://www.researchgate.net/publication/320869871_Vitamin_B17_and_its_Proposed_Application_in_Treating_Cancer0
2016Amygdalin inhibits the growth of renal cell carcinoma cells in vitroEva Juengel26709398https://pubmed.ncbi.nlm.nih.gov/26709398/0